Halo Labs is Now Part of Waters – Press Release and FAQs
Develop faster, smarter, safer by rethinking particle analysis
When you can count and identify visible and subvisible particles using microliter volumes at high throughput, you get powerful decision-driving data that accelerates biotherapeutic development from pre-IND into clinical phases and even manufacturing.
Particle Analyzers Designed For Biotherapeutic Workflows
Make decisions about candidate selection, formulation, quality, and safety based on clear and quickly-obtainable particle analysis data—powered by innovative Backgrounded Membrane Imaging (BMI) and Fluorescence Membrane Microscopy (FMM) technology.
Imagine How Much More You Can Accomplish With Aura Particle Analyzers
See What Makes Aura So Innovative
See What Makes Aura So Innovative
By rethinking how particle analysis is done:
- Conserving sample by removing the need for flow-based analysis
- Seeing everything by capturing all sample particles on a membrane
- Visualizing and identifying particles with high-magnification BMI and FMM
- Speeding analysis with low-volume, 96-well membrane plate analysis
Halo Labs brings particle analysis to earlier stages of the biotherapeutic development process while supporting manufacturing for USP 788.
*Dynabeads refers to the magnetic beads produced by Thermo Fisher Scientific, Inc. Halo Labs is not affiliated with Thermo Fisher Scientific, Inc., and references to Dynabeads or any other third-party trademark do not imply sponsorship, endorsement, or approval.
